First Wave BioPharma director Gregory Oakes resigns; board lowers quorum to one-third

GridAI Technologies Corp.

Gregory Oakes resigned from the Board effective June 16, 2022; no disagreement cited.
Board amended bylaws to reduce stockholder meeting quorum from majority to one-third of voting power.
Company filed Certificate of Correction clarifying Board's right to designate preferred stock series with/without voting powers, effective retroactively to July 13, 2016.
Exhibits 3.1 (bylaw amendment) and 3.2 (Certificate of Correction) filed with the SEC.

item 5.02 item 5.03 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gregory Oakes

Director

GRDX · GridAI Technologies Corp.

Effective: 2022-06-16
Filed: June 17, 2022, 7:59 PM ET

On June 16, 2022, Gregory Oakes submitted his resignation from the Board of Directors (the “Board”) of First Wave BioPharma, Inc. (the “Company”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gregory Oakes resigned as Director at GridAI Technologies Corp..

Action: resigned
Role: Director

Exact text from the filing

On June 16, 2022, Gregory Oakes submitted his resignation from the Board of Directors (the “Board”) of First Wave BioPharma, Inc. (the “Company”), effective immediately.

View on SEC.gov

GridAI Technologies Corp. filing history →

Source: SEC EDGAR

accession 0001104659-22-072444

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.